xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 2021, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22741 by Stanford University, Wiley Online Library on [01/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

710

International consensus statement on rhinosinusitis

ease: a randomized double-blind placebo-controlled trial. Clin Immunol . 2015;160(2):349-357. 1686. Mortazavi N, Esmaeilzadeh H, Abbasinazari M, et al. Clini cal and immunological efficacy of aspirin desensitization in nasal polyp patients with aspirin-exacerbated respiratory dis ease. Iran J Pharm Res . 2017;16(4):1639-1647. 1687. Klimek L, Dollner R, Pfaar O, Mullol J. Aspirin desensitiza tion: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)? Curr Allergy Asthma Rep . 2014;14(6):441. 1688. Parikh A, Scadding GK. Topical nasal lysine aspirin in aspirin sensitive and aspirin-tolerant chronic rhinosinusitis with nasal polyposis. Expert Rev Clin Immunol . 2014;10(5):657-665. 1689. Chu DK, Lee DJ, Lee KM, Schünemann HJ, Szczeklik W, Lee JM. Benefits and harms of aspirin desensitization for aspirin exacerbated respiratory disease: a systematic review and meta analysis. Int Forum Allergy Rhinol . 2019;9(12):1409-1419. 1690. Larivée N, Chin CJ. Aspirin desensitization therapy in aspirin exacerbated respiratory disease: a systematic review. Int Forum Allergy Rhinol . 2020;10(4):450-464. 1691. Uri N, Ronen O, Marshak T, Parpara O, Nashashibi M, Gruber M. Allergic fungal sinusitis and eosinophilic mucin rhinosi nusitis: diagnostic criteria. J Laryngol Otol . 2013;127(9):867-871. 1692. Callejas CA, Douglas RG. Fungal rhinosinusitis: what every allergist should know. Clin Exp Allergy . 2013;43(8):835-849. 1693. Hoyt AE, Borish L, Gurrola J, Payne S. Allergic fungal rhinos inusitis. J Allergy Clin Immunol Pract . 2016;4(4):599-604. 1694. Bent JP, Kuhn FA. Diagnosis of allergic fungal sinusitis. Oto laryngol Head Neck Surg . 1994;111:580-588. 1695. Tyler MA, Luong AU. Current understanding of allergic fun gal rhinosinusitis. World J Otorhinolaryngol Head Neck Surg . 2018;4(3):179-185. 1696. Ryan MW. Allergic fungal rhinosinusitis. Otolaryngol Clin NorthAm . 2011;44(3):697-710, ix-x. 1697. Clark DW, Wenaas A, Luong A, Citardi MJ, Fakhri S. Staphy lococcus aureus prevalence in allergic fungal rhinosinusitis vs other subsets of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol . 2013;3(2):89-93. 1698. Ghegan MD, Wise SK, Gorham E, Schlosser RJ. Socioeco nomic factors in allergic fungal rhinosinusitis with bone ero sion. AmJRhinol . 2007;21(5):560-563. 1699. Wise SK, Ghegan MD, Gorham E, Schlosser RJ. Socioeco nomic factors in the diagnosis of allergic fungal rhinosinusitis. Otolaryngol Head Neck Surg . 2008;138(1):38-42. 1700. Miller JD, Deal AM, McKinney KA, et al. Markers of disease severity and socioeconomic factors in allergic fungal rhinosi nusitis. Int Forum Allergy Rhinol . 2014;4(4):272-279. 1701. Ferguson BJ, Barnes L, Bernstein JM, et al. Geographic vari ation in allergic fungal rhinosinusitis. Otolaryngol Clin North Am . 2000;33(2):441-449. 1702. Chakrabarti A, Kaur H. Allergic aspergillus rhinosinusitis. J Fungi (Basel) . 2016;2(4):32. 1703. Mukherji SK, Figueroa RE, Ginsberg LE, et al. Allergic fungal sinusitis: CT findings. Radiology . 1998;207(2):417-422. 1704. Ghegan MD, Lee FS, Schlosser RJ. Incidence of skull base and orbital erosion in allergic fungal rhinosinusitis (AFRS) and non-AFRS. Otolaryngol Head Neck Surg . 2006;134(4):592-595.

1670. Stevenson DD, Pleskow WW, Simon RA, et al. Aspirin sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin. J Allergy Clin Immunol . 1984;73(4):500-507. 1671. Parikh AA, Scadding GK. Intranasal lysine-aspirin in aspirin sensitive nasal polyposis: a controlled trial. Laryngoscope . 2005;115(8):1385-1390. 1672. Pfaar O, Klimek L. Eicosanoids, aspirin-intolerance and the upper airways–current standards and recent improvements of the desensitization therapy. J Physiol Pharmacol . 2006;57 (Suppl 12):5-13. 1673. Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin sensitive patients with rhinosinusitis-asthma: long-term out comes. J Allergy Clin Immunol . 1996;98(4):751-758. 1674. Rozsasi A, Polzehl D, Deutschle T, et al. Long-term treatment with aspirin desensitization: a prospective clinical trial com paring 100 and 300 mg aspirin daily. Allergy . 2008;63(9):1228 1234. 1675. Adappa ND, Ranasinghe VJ, Trope M, et al. Outcomes after complete endoscopic sinus surgery and aspirin desensitiza tion in aspirin-exacerbated respiratory disease. Int Forum Allergy Rhinol . 2018;8(1):49-53. 1676. Cho KS, Soudry E, Psaltis AJ, et al. Long-term sinonasal out comes of aspirin desensitization in aspirin exacerbated res piratory disease. Otolaryngol Head Neck Surg . 2014;151(4):575 581. 1677. Ibrahim C, Singh K, Tsai G, et al. A retrospective study of the clinical benefit from acetylsalicylic acid desensitization in patients with nasal polyposis and asthma. Allergy Asthma Clin Immunol . 2014;10(1):64. 1678. Havel M, Ertl L, Braunschweig F, et al. Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad. Eur Arch Otorhi nolaryngol . 2013;270(2):571-578. 1679. Comert S, Celebioglu E, Yucel T, et al. Aspirin 300 mg/day is effective for treating aspirin-exacerbated respiratory disease. Allergy . 2013;68(11):1443-1451. 1680. Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol . 2003;111(1):180-186. 1681. Lee JY, Simon RA, Stevenson DD. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol . 2007;119(1):157-164. 1682. Lanas A, Wu P, Medin J, Mills EJ. Low doses of acetylsali cylic acid increase risk of gastrointestinal bleeding in a meta analysis. Clin Gastroenterol Hepatol . 2011;9(9):762-768.e766. 1683. Moberg C, Naesdal J, Svedberg LE, Duchateau D, Harte N. Impact of gastrointestinal problems on adherence to low-dose acetylsalicylic Acid:a quantitative study in patients with car diovascular risk. Patient . 2011;4(2):103-113. 1684. Fruth K, Pogorzelski B, Schmidtmann I, et al. Low dose aspirin desensitization in individuals with aspirin exacerbated respiratory disease. Allergy . 2013;68(5):659-665. 1685. Esmaeilzadeh H, Nabavi M, Aryan Z, et al. Aspirin desensi tization for patients with aspirin-exacerbated respiratory dis